These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38505600)

  • 21. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
    Wang H; Yang Z; Jiang Y; Hartnett ME
    Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
    Chen J; Sun Y; Chen L; Zhou Y
    Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression.
    Liu L; Xu H; Zhao H; Sui D
    J Drug Target; 2021 Mar; 29(3):300-309. PubMed ID: 33032456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas.
    Sun L; Wang R; Hu G; Liu H; Lv K; Duan Y; Shen N; Wu J; Hu J; Liu Y; Jin Q; Zhang F; Xu X
    Exp Eye Res; 2021 Sep; 210():108718. PubMed ID: 34364890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin-Interacting Protein Inhibited Vascular Endothelial Cell-Induced HREC Angiogenesis Treatment of Diabetic Retinopathy.
    Yan J; Deng J; Cheng F; Zhang T; Deng Y; Cai Y; Cong W
    Appl Biochem Biotechnol; 2023 Feb; 195(2):1268-1283. PubMed ID: 36346561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
    Han N; Tian W; Yu N; Yu L
    J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidative effects of polypyrimidine tract-binding protein-associated splicing factor against pathological retinal angiogenesis through promotion of mitochondrial function.
    Dong L; Lin T; Li W; Hong Y; Ren X; Ke Y; Zhang X; Li X
    J Mol Med (Berl); 2021 Jul; 99(7):967-980. PubMed ID: 33770188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of glycoprotein non-metastatic melanoma protein B prevents high glucose-induced angiogenesis in diabetic retinopathy.
    Qin T; Xi X; Wu Z
    Mol Cell Biochem; 2023 Apr; 478(4):697-706. PubMed ID: 36036335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway.
    Niu C; Chen Z; Kim KT; Sun J; Xue M; Chen G; Li S; Shen Y; Zhu Z; Wang X; Liang J; Jiang C; Cong W; Jin L; Li X
    Autophagy; 2019 May; 15(5):843-870. PubMed ID: 30653446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression.
    Zhu W; Gui X; Zhou Y; Gao X; Zhang R; Li Q; Zhang H; Zhao J; Cui X; Gao G; Tang H; Huan C; Pan D; Song H; Zhou Z; Shen W
    Exp Eye Res; 2024 Feb; 239():109753. PubMed ID: 38142764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.
    Zhao F; Gao X; Ge X; Cui J; Liu X
    Bioengineered; 2021 Dec; 12(2):9266-9278. PubMed ID: 34699316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Krüppel-Like Factor 9 Inhibits Aberrant Retinal Angiogenesis and Mitigates Proliferative Diabetic Retinopathy.
    Han N; Zhang L; Guo M; Yu L
    Mol Biotechnol; 2023 Apr; 65(4):612-623. PubMed ID: 36109428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of pentraxin 3 on pathological retinal angiogenesis in an in vitro model of diabetic retinopathy.
    Jiang Y; Xing X; Niu T; Wang H; Wang C; Shi X; Liu K; Su L
    Arch Biochem Biophys; 2022 Aug; 725():109283. PubMed ID: 35577071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy.
    Dong L; Zhang Z; Liu X; Wang Q; Hong Y; Li X; Liu J
    J Mol Med (Berl); 2021 Feb; 99(2):225-240. PubMed ID: 33188599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT1 Deletion Impairs Retinal Endothelial Cell Migration Through Downregulation of VEGF-A/VEGFR-2 and MMP14.
    Lin Y; Li L; Liu J; Zhao X; Ye J; Reinach PS; Qu J; Yan D
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5431-5440. PubMed ID: 30452596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of microRNA-15b promotes the proliferation of retinal capillary endothelial cells and pericytes by up-regulating VEGFA in diabetic rats.
    Xu Y; Xie SC; Ma YC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6018-6025. PubMed ID: 31364104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Gα
    Leiss V; Schönsiegel A; Gnad T; Kerner J; Kaur J; Sartorius T; Machann J; Schick F; Birnbaumer L; Häring HU; Pfeifer A; Nürnberg B
    Mol Metab; 2020 Oct; 40():101029. PubMed ID: 32480042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
    Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
    Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
    FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.